Eli Lilly agreed to buy closely held Ajax Therapeutics for as much as $2.3 billion in cash, underscoring continued pharma dealmaking. Sun Pharmaceutical Industries also agreed to acquire New York-listed women’s health-care company Organon, adding to sector consolidation. The moves are positive for M&A sentiment in healthcare, though the article is primarily a brief market wrap rather than a company-specific earnings event.
Eli Lilly agreed to buy closely held Ajax Therapeutics for as much as $2.3 billion in cash, underscoring continued pharma dealmaking. Sun Pharmaceutical Industries also agreed to acquire New York-listed women’s health-care company Organon, adding to sector consolidation. The moves are positive for M&A sentiment in healthcare, though the article is primarily a brief market wrap rather than a company-specific earnings event.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
